Rheumatoid Arthritis and Pure Red Cell Aplasia

  1. EMMANUEL N. DESSYPRIS, M.D.;
  2. MARIA R. BAER, M.D.;
  3. JOHN S. SERGENT, M.D.; and
  4. SANFORD B. KRANTZ, M.D.
  1. Nashville, Tennessee

    Abstract

    Three patients with severe, deforming, and long-standing rheumatoid arthritis developed pure red cell aplasia that did not remit after withdrawal of medications, ran a chronic course, and in two patients remitted only after cytotoxic immunosuppressive treatment. An IgG inhibitor of autologous erythroid colony-forming and burst-forming unit growth in vitro was found in the serum of one patient. This specific erythropoietic inhibitor persisted in lower titer in the patient's serum even after an azathioprine-induced remission of pure red cell aplasia, indicating the possible need for maintenance immunosuppressive therapy. Chronic pure red cell aplasia may be another extra-articular manifestation of rheumatoid arthritis and should be considered when severe anemia develops in the absence of blood loss or hemolysis.

    Article and Author Information

    • ▸From the Divisions of Hematology and Rheumatology, Veterans Administration Medical Center, and the Vanderbilt University School of Medicine; Nashville, Tennessee.

    • Grant support: in part by the Veterans Administration, grant RR-95 from the General Clinical Research Centers Program of the Division of Research Resources, and grants AM-15555 and T32 AM-07186 from the National Institutes of Health.

    • ▸Requests for reprints should be addressed to Emmanuel N. Dessypris, M.D.; Veterans Administration Medical Center, 1310 24th Avenue South; Nashville, TN 37203.

    « Previous | Next Article »Table of Contents